MAPK1 and prostate cancer: Furthermore, enriched pathway terms were mainly associated with ECM–receptor interactions, RAF-independent MAPK1/3 activation, collagen biosynthesis and modifying enzymes, prostate cancer, platelet homeostasis, NCAM1 interactions, and signaling by NTRKs (Figure 4C).